231 related articles for article (PubMed ID: 19874420)
1. Isthmin is a novel secreted angiogenesis inhibitor that inhibits tumour growth in mice.
Xiang W; Ke Z; Zhang Y; Cheng GH; Irwan ID; Sulochana KN; Potturi P; Wang Z; Yang H; Wang J; Zhuo L; Kini RM; Ge R
J Cell Mol Med; 2011 Feb; 15(2):359-74. PubMed ID: 19874420
[TBL] [Abstract][Full Text] [Related]
2. Isthmin targets cell-surface GRP78 and triggers apoptosis via induction of mitochondrial dysfunction.
Chen M; Zhang Y; Yu VC; Chong YS; Yoshioka T; Ge R
Cell Death Differ; 2014 May; 21(5):797-810. PubMed ID: 24464222
[TBL] [Abstract][Full Text] [Related]
3. Peptides derived from human decorin leucine-rich repeat 5 inhibit angiogenesis.
Sulochana KN; Fan H; Jois S; Subramanian V; Sun F; Kini RM; Ge R
J Biol Chem; 2005 Jul; 280(30):27935-48. PubMed ID: 15923192
[TBL] [Abstract][Full Text] [Related]
4. Eriocalyxin B, a natural diterpenoid, inhibited VEGF-induced angiogenesis and diminished angiogenesis-dependent breast tumor growth by suppressing VEGFR-2 signaling.
Zhou X; Yue GG; Liu M; Zuo Z; Lee JK; Li M; Tsui SK; Fung KP; Sun H; Pu J; Lau CB
Oncotarget; 2016 Dec; 7(50):82820-82835. PubMed ID: 27756875
[TBL] [Abstract][Full Text] [Related]
5. Isthmin exerts pro-survival and death-promoting effect on endothelial cells through alphavbeta5 integrin depending on its physical state.
Zhang Y; Chen M; Venugopal S; Zhou Y; Xiang W; Li YH; Lin Q; Kini RM; Chong YS; Ge R
Cell Death Dis; 2011 May; 2(5):e153. PubMed ID: 21544092
[TBL] [Abstract][Full Text] [Related]
6. Angio-3, a 10-residue peptide derived from human plasminogen kringle 3, suppresses tumor growth in mice via impeding both angiogenesis and vascular permeability.
Venugopal S; Kao C; Chandna R; Sulochana KN; Subramanian V; Chen M; Kini RM; Ge R
Angiogenesis; 2018 Aug; 21(3):653-665. PubMed ID: 29691683
[TBL] [Abstract][Full Text] [Related]
7. The adaptor protein Shc integrates growth factor and ECM signaling during postnatal angiogenesis.
Sweet DT; Chen Z; Wiley DM; Bautch VL; Tzima E
Blood; 2012 Feb; 119(8):1946-55. PubMed ID: 22096252
[TBL] [Abstract][Full Text] [Related]
8. Clinically relevant concentrations of lidocaine inhibit tumor angiogenesis through suppressing VEGF/VEGFR2 signaling.
Gao J; Hu H; Wang X
Cancer Chemother Pharmacol; 2019 Jun; 83(6):1007-1015. PubMed ID: 30887179
[TBL] [Abstract][Full Text] [Related]
9. Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor.
Sun J; Blaskovich MA; Jain RK; Delarue F; Paris D; Brem S; Wotoczek-Obadia M; Lin Q; Coppola D; Choi K; Mullan M; Hamilton AD; Sebti SM
Cancer Res; 2004 May; 64(10):3586-92. PubMed ID: 15150116
[TBL] [Abstract][Full Text] [Related]
10. Rhodostomin, a snake venom disintegrin, inhibits angiogenesis elicited by basic fibroblast growth factor and suppresses tumor growth by a selective alpha(v)beta(3) blockade of endothelial cells.
Yeh CH; Peng HC; Yang RS; Huang TF
Mol Pharmacol; 2001 May; 59(5):1333-42. PubMed ID: 11306719
[TBL] [Abstract][Full Text] [Related]
11. Dual blockade of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF-2) exhibits potent anti-angiogenic effects.
Li D; Xie K; Zhang L; Yao X; Li H; Xu Q; Wang X; Jiang J; Fang J
Cancer Lett; 2016 Jul; 377(2):164-73. PubMed ID: 27130666
[TBL] [Abstract][Full Text] [Related]
12. Recombinant semaphorin 6A-1 ectodomain inhibits in vivo growth factor and tumor cell line-induced angiogenesis.
Dhanabal M; Wu F; Alvarez E; McQueeney KD; Jeffers M; MacDougall J; Boldog FL; Hackett C; Shenoy S; Khramtsov N; Weiner J; Lichenstein HS; LaRochelle WJ
Cancer Biol Ther; 2005 Jun; 4(6):659-68. PubMed ID: 15917651
[TBL] [Abstract][Full Text] [Related]
13. Kallistatin is a new inhibitor of angiogenesis and tumor growth.
Miao RQ; Agata J; Chao L; Chao J
Blood; 2002 Nov; 100(9):3245-52. PubMed ID: 12384424
[TBL] [Abstract][Full Text] [Related]
14. SKLB1002, a novel potent inhibitor of VEGF receptor 2 signaling, inhibits angiogenesis and tumor growth in vivo.
Zhang S; Cao Z; Tian H; Shen G; Ma Y; Xie H; Liu Y; Zhao C; Deng S; Yang Y; Zheng R; Li W; Zhang N; Liu S; Wang W; Dai L; Shi S; Cheng L; Pan Y; Feng S; Zhao X; Deng H; Yang S; Wei Y
Clin Cancer Res; 2011 Jul; 17(13):4439-50. PubMed ID: 21622720
[TBL] [Abstract][Full Text] [Related]
15. Isthmin inhibits glioma growth through antiangiogenesis in vivo.
Yuan B; Xian R; Ma J; Chen Y; Lin C; Song Y
J Neurooncol; 2012 Sep; 109(2):245-52. PubMed ID: 22772605
[TBL] [Abstract][Full Text] [Related]
16. Endostar attenuates melanoma tumor growth via its interruption of b-FGF mediated angiogenesis.
Xiao L; Yang S; Hao J; Yuan X; Luo W; Jiang L; Hu Y; Fu Z; Zhang Y; Zou C
Cancer Lett; 2015 Apr; 359(1):148-54. PubMed ID: 25597785
[TBL] [Abstract][Full Text] [Related]
17. Barbigerone inhibits tumor angiogenesis, growth and metastasis in melanoma.
Yang JH; Hu J; Wan L; Chen LJ
Asian Pac J Cancer Prev; 2014; 15(1):167-74. PubMed ID: 24528020
[TBL] [Abstract][Full Text] [Related]
18. Endothelial Cells Require CD98 for Efficient Angiogenesis-Brief Report.
Liao Z; Cantor JM
Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2163-2166. PubMed ID: 27687603
[TBL] [Abstract][Full Text] [Related]
19. Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis.
Cheng N; Brantley DM; Liu H; Lin Q; Enriquez M; Gale N; Yancopoulos G; Cerretti DP; Daniel TO; Chen J
Mol Cancer Res; 2002 Nov; 1(1):2-11. PubMed ID: 12496364
[TBL] [Abstract][Full Text] [Related]
20. Basic fibroblast growth factor induces VEGF expression in chondrosarcoma cells and subsequently promotes endothelial progenitor cell-primed angiogenesis.
Tzeng HE; Chen PC; Lin KW; Lin CY; Tsai CH; Han SM; Teng CL; Hwang WL; Wang SW; Tang CH
Clin Sci (Lond); 2015 Jul; 129(2):147-58. PubMed ID: 25735814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
